Cargando…

Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas

Meningoencephalitis caused by free-living amoebas (FLA) has a high mortality rate, and most treatments are ineffective. FLA includes Naegleria, Fowleri, Acanthamoeba, and Balamuthia mandrillaris (M). We explore the use of miltefosine in the treatment of one of these infections. The concerning mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Alli, Ammar, Ortiz, Juan Fernando, Morillo Cox, Álvaro, Armas, Maria, Orellana, Victor A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020194/
https://www.ncbi.nlm.nih.gov/pubmed/33833918
http://dx.doi.org/10.7759/cureus.13698
_version_ 1783674536226455552
author Alli, Ammar
Ortiz, Juan Fernando
Morillo Cox, Álvaro
Armas, Maria
Orellana, Victor A
author_facet Alli, Ammar
Ortiz, Juan Fernando
Morillo Cox, Álvaro
Armas, Maria
Orellana, Victor A
author_sort Alli, Ammar
collection PubMed
description Meningoencephalitis caused by free-living amoebas (FLA) has a high mortality rate, and most treatments are ineffective. FLA includes Naegleria, Fowleri, Acanthamoeba, and Balamuthia mandrillaris (M). We explore the use of miltefosine in the treatment of one of these infections. The concerning mortality of the infection obligates us to look for more effective treatments for meningoencephalitis caused by FLA. During this review, we will consolidate the knowledge of using miltefosine in these three infections. We will investigate the mechanism by which the drug is effective in these infections as well. After this comprehensive review, we should assess if miltefosine improves the mortality and prognosis of the infection with the information collected. We used a Medical Subject Headings (MeSH) search on PubMed. Inclusion criteria included papers written in the English language and human subjects research for the past 25 years. Until today, there are no definitive guidelines to be followed when treating such patients. However, miltefosine has demonstrated promising results. Miltefosine decreases the usual mortality rate in the three infections; however, there are few reports due to the low frequency of these infections. Almost all cases we documented have survived. More information needs to be gathered for the use of miltefosine for these infections.
format Online
Article
Text
id pubmed-8020194
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-80201942021-04-07 Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas Alli, Ammar Ortiz, Juan Fernando Morillo Cox, Álvaro Armas, Maria Orellana, Victor A Cureus Neurology Meningoencephalitis caused by free-living amoebas (FLA) has a high mortality rate, and most treatments are ineffective. FLA includes Naegleria, Fowleri, Acanthamoeba, and Balamuthia mandrillaris (M). We explore the use of miltefosine in the treatment of one of these infections. The concerning mortality of the infection obligates us to look for more effective treatments for meningoencephalitis caused by FLA. During this review, we will consolidate the knowledge of using miltefosine in these three infections. We will investigate the mechanism by which the drug is effective in these infections as well. After this comprehensive review, we should assess if miltefosine improves the mortality and prognosis of the infection with the information collected. We used a Medical Subject Headings (MeSH) search on PubMed. Inclusion criteria included papers written in the English language and human subjects research for the past 25 years. Until today, there are no definitive guidelines to be followed when treating such patients. However, miltefosine has demonstrated promising results. Miltefosine decreases the usual mortality rate in the three infections; however, there are few reports due to the low frequency of these infections. Almost all cases we documented have survived. More information needs to be gathered for the use of miltefosine for these infections. Cureus 2021-03-04 /pmc/articles/PMC8020194/ /pubmed/33833918 http://dx.doi.org/10.7759/cureus.13698 Text en Copyright © 2021, Alli et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Alli, Ammar
Ortiz, Juan Fernando
Morillo Cox, Álvaro
Armas, Maria
Orellana, Victor A
Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title_full Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title_fullStr Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title_full_unstemmed Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title_short Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
title_sort miltefosine: a miracle drug for meningoencephalitis caused by free-living amoebas
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020194/
https://www.ncbi.nlm.nih.gov/pubmed/33833918
http://dx.doi.org/10.7759/cureus.13698
work_keys_str_mv AT alliammar miltefosineamiracledrugformeningoencephalitiscausedbyfreelivingamoebas
AT ortizjuanfernando miltefosineamiracledrugformeningoencephalitiscausedbyfreelivingamoebas
AT morillocoxalvaro miltefosineamiracledrugformeningoencephalitiscausedbyfreelivingamoebas
AT armasmaria miltefosineamiracledrugformeningoencephalitiscausedbyfreelivingamoebas
AT orellanavictora miltefosineamiracledrugformeningoencephalitiscausedbyfreelivingamoebas